Neuronal IκB kinase β protects mice from autoimmune encephalomyelitis by mediating neuroprotective and immunosuppressive effects in the central nervous system

Journal of Immunology

Volumn 183, Issue 12, 2009, Pages 7877-7889

  Emmanouil, Mary ^a   Taoufik, Era ^a   Tseveleki, Vivian ^a   Vamvakas, Sotiris Spyros ^a   Tselios, Theodore ^b   Karin, Michael ^c   Lassmann, Hans ^d   Probert, Lesley ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c San Diego   (United States)

^d Medical University of Vienna   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CALMODULIN; CD30 LIGAND; CHEMOKINE; COLONY STIMULATING FACTOR RECEPTOR; FLICE INHIBITORY PROTEIN; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 6; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TUMOR NECROSIS FACTOR; VASCULOTROPIN; AUTACOID; I KAPPA B KINASE; IMMUNOSUPPRESSIVE AGENT;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; MONOCYTE; MOUSE; NATURAL KILLER CELL; NERVE CELL; NERVE FIBER; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; ANIMAL; C57BL MOUSE; CELL DEATH; CHRONIC DISEASE; ENZYMOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; MIGRATION INHIBITION; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; AXONS; CELL DEATH; CELL MIGRATION INHIBITION; CENTRAL NERVOUS SYSTEM; CHRONIC DISEASE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; I-KAPPA B KINASE; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION MEDIATORS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONS; TH1 CELLS;

EID: 76249086119     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900834     Document Type: Article

References (75)

1. Sospedra, M., and R. Martin. 2005. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23: 683-747.
2. Dutta, R., and B. D. Trapp. 2007. Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 68: S22-S31. (Pubitemid 46848608)
3. Lassmann, H. 2007. New concepts on progressive multiple sclerosis. Curr. Neurol. Neurosci. Rep. 7: 239-244. (Pubitemid 46831518)
4. Hohlfeld, R., M. Kerschensteiner, C. Stadelmann, H. Lassmann, and H. Wekerle. 2006. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. Neurol. Sci. 27(Suppl. 1): S1-S7. (Pubitemid 43756787)
5. Trapp, B. D., and K. A. Nave. 2008. Multiple sclerosis: an immune or neurodegenerative disorder? Annu. Rev. Neurosci. 31: 247-269.
6. Neumann, H., and H. Wekerle. 1998. Neuronal control of the immune response in the central nervous system: linking brain immunity to neurodegeneration. J. Neuropathol. Exp. Neurol. 57: 1-9. (Pubitemid 28057171)
7. Neumann, H., H. Schmidt, A. Cavalie, D. Jenne, and H. Wekerle. 1997. Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: differential regulation by interferon (IFN)-γ and tumor necrosis factor (TNF)-α. J. Exp. Med. 185: 305-316. (Pubitemid 27078287)
8. Hoek, R. M., S. R. Ruuls, C. A. Murphy, G. J. Wright, R. Goddard, S. M. Zurawski, B. Blom, M. E. Homola, W. J. Streit, M. H. Brown, et al. 2000. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 290: 1768-1771.
9. Mott, R. T., G. Ait-Ghezala, T. Town, T. Mori, M. Vendrame, J. Zeng, J. Ehrhart, M. Mullan, and J. Tan. 2004. Neuronal expression of CD22: novel mechanism for inhibiting microglial proinflammatory cytokine production. Glia 46: 369-379.
10. Flugel, A., F. W. Schwaiger, H. Neumann, I. Medana, M. Willem, H. Wekerle, G. W. Kreutzberg, and M. B. Graeber. 2000. Neuronal FasL induces cell death of encephalitogenic T lymphocytes. Brain Pathol. 10: 353-364. (Pubitemid 30431288)
11. Tian, L., Y. Yoshihara, T. Mizuno, K. Mori, and C. G. Gahmberg. 1997. The neuronal glycoprotein telencephalin is a cellular ligand for the CD11a/CD18 leukocyte integrin. J. Immunol. 158: 928-936. (Pubitemid 127492673)
12. Tian, L., P. Kilgannon, Y. Yoshihara, K. Mori, W. M. Gallatin, O. Carpen, and C. G. Gahmberg. 2000. Binding of T lymphocytes to hippocampal neurons through ICAM-5 (telencephalin) and characterization of its interaction with the leukocyte integrin CD11a/CD18. Eur. J. Immunol. 30: 810-818. (Pubitemid 30216253)
13. Liu, Y., I. Teige, B. Birnir, and S. Issazadeh-Navikas. 2006. Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat. Med. 12: 518-525.
14. Cheng, B., S. Christakos, and M. P. Mattson. 1994. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 12: 139-153. (Pubitemid 24044394)
15. Bruce, A. J., W. Boling, M. S. Kindy, J. Peschon, P. J. Kraemer, M. K. Carpenter, F. W. Holtsberg, and M. P. Mattson. 1996. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. 2: 788-794.
16. L protects neurons against in vivo ischemia and in vitro glucose deprivation-induced cell death. J. Neurosci. 27: 6633-6646.
17. Lambertsen, K. L., B. H. Clausen, A. A. Babcock, R. Gregersen, C. Fenger, H. H. Nielsen, L. S. Haugaard, M. Wirenfeldt, M. Nielsen, F. Dagnaes-Hansen, et al. 2009. Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J. Neurosci. 29: 1319-1330.
18. Taoufik, E., E. Petit, D. Divoux, V. Tseveleki, M. Mengozzi, M. L. Roberts, S. Valable, P. Ghezzi, J. Quackenbush, M. Brines, et al. 2008. TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury. Proc. Natl. Acad. Sci. USA 105: 6185-6190.
19. Li, Q., and I. M. Verma. 2002. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2: 725-734.
20. Karin, M., and A. Lin. 2002. NF-κB at the crossroads of life and death. Nat. Immunol. 3: 221-227.
21. Rius, J., M. Guma, C. Schachtrup, K. Akassoglou, A. S. Zinkernagel, V. Nizet, R. S. Johnson, G. G. Haddad, and M. Karin. 2008. NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α. Nature 453: 807-811.
22. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-κB puzzle. Cell 109(Suppl.): S81-S96.
23. Meffert, M. K., J. M. Chang, B. J. Wiltgen, M. S. Fanselow, and D. Baltimore. 2003. NF-κB functions in synaptic signaling and behavior. Nat. Neurosci. 6: 1072-1078.
24. Albensi, B. C., and M. P. Mattson. 2000. Evidence for the involvement of TNF and NF-κB in hippocampal synaptic plasticity. Synapse 35: 151-159.
25. Kaltschmidt, B., D. Ndiaye, M. Korte, S. Pothion, L. Arbibe, M. Prullage, J. Pfeiffer, A. Lindecke, V. Staiger, A. Israel, et al. 2006. NF-κB regulates spatial memory formation and synaptic plasticity through protein kinase A/CREB signaling. Mol. Cell. Biol. 26: 2936-2946.
26. Schneider, A., A. Martin-Villalba, F. Weih, J. Vogel, T. Wirth, and M. Schwaninger. 1999. NF-κB is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 5: 554-559.
27. Mattson, M. P., Y. Goodman, H. Luo, W. Fu, and K. Furukawa. 1997. Activation of NF-κB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49: 681-697.
28. Bhakar, A. L., L. L. Tannis, C. Zeindler, M. P. Russo, C. Jobin, D. S. Park, S. MacPherson, and P. A. Barker. 2002. Constitutive nuclear factor-κB activity is required for central neuron survival. J. Neurosci. 22: 8466-8475.
29. Fridmacher, V., B. Kaltschmidt, B. Goudeau, D. Ndiaye, F. M. Rossi, J. Pfeiffer, C. Kaltschmidt, A. Israel, and S. Memet. 2003. Forebrain-specific neuronal inhibition of nuclear factor-κB activity leads to loss of neuroprotection. J. Neurosci. 23: 9403-9408.
30. Herrmann, O., B. Baumann, R. de Lorenzi, S. Muhammad, W. Zhang, J. Kleesiek, M. Malfertheiner, M. Kohrmann, I. Potrovita, I. Maegele, et al. 2005. IKK mediates ischemia-induced neuronal death. Nat. Med. 11: 1322-1329.
31. Zhang, W., I. Potrovita, V. Tarabin, O. Herrmann, V. Beer, F. Weih, A. Schneider, and M. Schwaninger. 2005. Neuronal activation of NF-κB contributes to cell death in cerebral ischemia. J. Cereb. Blood Flow Metab. 25: 30-40. (Pubitemid 40096895)
32. van Loo, G., R. De Lorenzi, H. Schmidt, M. Huth, A. Mildner, M. Schmidt-Supprian, H. Lassmann, M. R. Prinz, and M. Pasparakis. 2006. Inhibition of transcription factor NF-κB in the central nervous system ameliorates autoimmune encephalomyelitis in mice. Nat. Immunol. 7: 954-961. (Pubitemid 44263909)
33. Brambilla, R., T. Persaud, X. Hu, S. Karmally, V. I. Shestopalov, G. Dvoriantchikova, D. Ivanov, L. Nathanson, S. R. Barnum, and J. R. Bethea. 2009. Transgenic inhibition of astroglial NF-κB improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation. J. Immunol. 182: 2628-2640.
34. Youssef, S., and L. Steinman. 2006. At once harmful and beneficial: the dual properties of NF-κB. Nat. Immunol. 7: 901-902. (Pubitemid 44263900)
35. Park, J. M., F. R. Greten, Z. W. Li, and M. Karin. 2002. Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297: 2048-2051.
36. Li, Z. W., S. A. Omori, T. Labuda, M. Karin, and R. C. Rickert. 2003. IKKβ is required for peripheral B cell survival and proliferation. J. Immunol. 170: 4630-4637. (Pubitemid 36519969)
37. Minichiello, L., M. Korte, D. Wolfer, R. Kuhn, K. Unsicker, V. Cestari, C. Rossi-Arnaud, H. P. Lipp, T. Bonhoeffer, and R. Klein. 1999. Essential role for TrκB receptors in hippocampus-mediated learning. Neuron 24: 401-414. (Pubitemid 29508413)
38. Soriano, P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21: 70-71. (Pubitemid 29036285)
39. 81 carboxyl group and of a cyclic conformation for induction of experimental allergic encephalomyelitis. J. Med. Chem. 42: 1170-1177.
40. Tselios, T., I. Daliani, S. Deraos, S. Thymianou, E. Matsoukas, A. Troganis, I. Gerothanassis, A. Mouzaki, T. Mavromoustakos, L. Probert, and J. Matsoukas. 2000. Treatment of experimental allergic encephalomyelitis (EAE) by a rationally designed cyclic analogue of myelin basic protein (MBP) epitope 72-85. Bioorg. Med. Chem. Lett. 10: 2713-2717.
41. Tseveleki, V., J. Bauer, E. Taoufik, C. Ruan, L. Leondiadis, S. Haralambous, H. Lassmann, and L. Probert. 2004. Cellular FLIP (long isoform) overexpression in T cells drives Th2 effector responses and promotes immunoregulation in experimental autoimmune encephalomyelitis. J. Immunol. 173: 6619-6626.
42. Krishnamoorthy, G., H. Lassmann, H. Wekerle, and A. Holz. 2006. Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation. J. Clin. Invest. 116: 2385-2392. (Pubitemid 44330137)
43. Rossler, K., C. Neuchrist, K. Kitz, O. Scheiner, D. Kraft, and H. Lassmann. 1992. Expression of leucocyte adhesion molecules at the human blood-brain barrier (BBB). J. Neurosci. Res. 31: 365-374.
44. Nicole, O., C. Ali, F. Docagne, L. Plawinski, E. T. MacKenzie, D. Vivien, and A. Buisson. 2001. Neuroprotection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway. J. Neurosci. 21: 3024-3033. (Pubitemid 32323484)
45. Koh, J. Y., and D. W. Choi. 1987. Effect of anticonvulsant drugs on glutamate neurotoxicity in cortical cell culture. Neurology 37: 319-322.
46. Kornek, B., M. K. Storch, J. Bauer, A. Djamshidian, R. Weissert, E. Wallstroem, A. Stefferl, F. Zimprich, T. Olsson, C. Linington, et al. 2001. Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain 124: 1114-1124.
47. Brand-Schieber, E., and P. Werner. 2004. Calcium channel blockers ameliorate disease in a mouse model of multiple sclerosis. Exp. Neurol. 189: 5-9.
48. Sheldon, R. A., D. Osredkar, C. L. Lee, X. Jiang, D. Mu, and D. M. Ferriero. 2009. HIF-1α-deficient mice have increased brain injury after neonatal hypoxiaischemia. Dev. Neurosci. 31: 452-458.
49. Gold, R., C. Linington, and H. Lassmann. 2006. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129: 1953-1971.
50. Kreuz, S., D. Siegmund, P. Scheurich, and H. Wajant. 2001. NF-κB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol. Cell. Biol. 21: 3964-3973.
51. Karin, M., Y. Yamamoto, and Q. M. Wang. 2004. The IKK NF-κB system: a treasure trove for drug development. Nat. Rev. Drug Discov. 3: 17-26. (Pubitemid 38088695)
52. Mattson, M. P., and S. Camandola. 2001. NF-κB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 107: 247-254. (Pubitemid 32162153)
53. Kaltschmidt, B., D. Widera, and C. Kaltschmidt. 2005. Signaling via NF-κB in the nervous system. Biochim. Biophys. Acta 1745: 287-299.
54. Schmidt, D., B. Textor, O. T. Pein, A. H. Licht, S. Andrecht, M. Sator-Schmitt, N. E. Fusenig, P. Angel, and M. Schorpp-Kistner. 2007. Critical role for NF-κB-induced JunB in VEGF regulation and tumor angiogenesis. EMBO J. 26: 710-719.
55. Bernaudin, M., A. S. Nedelec, D. Divoux, E. T. MacKenzie, E. Petit, and P. Schumann-Bard. 2002. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxiainducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J. Cereb. Blood Flow Metab. 22: 393-403.
56. Jin, K. L., X. O. Mao, and D. A. Greenberg. 2000. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc. Natl. Acad. Sci. USA 97: 10242-10247.
57. Sun, Y., K. Jin, L. Xie, J. Childs, X. O. Mao, A. Logvinova, and D. A. Greenberg. 2003. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J. Clin. Invest. 111: 1843-1851. (Pubitemid 38057729)
58. Zheng, C., I. Nennesmo, B. Fadeel, and J. I. Henter. 2004. Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS. Ann. Neurol. 56: 564-567. (Pubitemid 39319348)
59. Storkebaum, E., D. Lambrechts, M. Dewerchin, M. P. Moreno-Murciano, S. Appelmans, H. Oh, P. Van Damme, B. Rutten, W. Y. Man, M. De Mol, et al. 2005. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat. Neurosci. 8: 85-92.
60. Wang, Y., O. Berezovska, and S. Fedoroff. 1999. Expression of colony stimulating factor-1 receptor (CSF-1R) by CNS neurons in mice. J. Neurosci. Res. 57: 616-632.
61. Jelinsky, S. A., J. S. Miyashiro, K. A. Saraf, C. Tunkey, P. Reddy, J. Newcombe, J. L. Oestreicher, E. Brown, W. L. Trepicchio, J. P. Leonard, and S. Marusic. 2005. Exploiting genotypic differences to identify genes important for EAE development. J. Neurol. Sci. 239: 81-93.
62. Michaelson, M. D., P. L. Bieri, M. F. Mehler, H. Xu, J. C. Arezzo, J. W. Pollard, and J. A. Kessler. 1996. CSF-1 deficiency in mice results in abnormal brain development. Development 122: 2661-2672.
63. Berezovskaya, O., D. Maysinger, and S. Fedoroff. 1995. The hematopoietic cytokine, colony-stimulating factor 1, is also a growth factor in the CNS: congenital absence of CSF-1 in mice results in abnormal microglial response and increased neuron vulnerability to injury. Int. J. Dev. Neurosci. 13: 285-299.
64. Berezovskaya, O., D. Maysinger, and S. Fedoroff. 1996. Colony stimulating factor-1 potentiates neuronal survival in cerebral cortex ischemic lesion. Acta Neuropathol. 92: 479-486.
65. Biber, K., H. Neumann, K. Inoue, and H. W. Boddeke. 2007. Neuronal "On" and "Off" signals control microglia. Trends Neurosci. 30: 596-602.
66. Brionne, T. C., I. Tesseur, E. Masliah, and T. Wyss-Coray. 2003. Loss of TGF-β1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron 40: 1133-1145.
67. Neumann, H., A. Cavalie, D. E. Jenne, and H. Wekerle. 1995. Induction of MHC class I genes in neurons. Science 269: 549-552.
68. Neumann, H., T. Misgeld, K. Matsumuro, and H. Wekerle. 1998. Neurotrophins inhibit major histocompatibility class II inducibility of microglia: involvement of the p75 neurotrophin receptor. Proc. Natl. Acad. Sci. USA 95: 5779-5784.
69. Majed, H. H., S. Chandran, S. P. Niclou, R. S. Nicholas, A. Wilkins, M. G. Wing, K. E. Rhodes, M. G. Spillantini, and A. Compston. 2006. A novel role for Sema3A in neuroprotection from injury mediated by activated microglia. J. Neurosci. 26: 1730-1738.
70. Savarin-Vuaillat, C., and R. M. Ransohoff. 2007. Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce? Neurotherapeutics 4: 590-601.
71. + CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. J. Exp. Med. 205: 811-823.
72. Kroenke, M. A., T. J. Carlson, A. V. Andjelkovic, and B. M. Segal. 2008. IL-12-and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 205: 1535-1541.
73. Segal, B. M. 2007. The role of natural killer cells in curbing neuroinflammation. J. Neuroimmunol. 191: 2-7.
74. Fontaine, V., S. Mohand-Said, N. Hanoteau, C. Fuchs, K. Pfizenmaier, and U. Eisel. 2002. Neurodegenerative and neuroprotective effects of tumor Necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J. Neurosci. 22: RC216.
75. Marchetti, L., M. Klein, K. Schlett, K. Pfizenmaier, and U. L. Eisel. 2004. Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation: essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-κB pathway. J. Biol. Chem. 279: 32869-32881.